Distinct genomic and immunologic tumor evolution in germline TP53 -driven breast cancers.

Autor: Boruah N; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hoyos D; Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Moses R; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hausler R; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Desai H; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Le AN; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Good M; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Kelly G; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Raghavakaimal A; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Tayeb M; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Narasimhamurthy M; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA., Doucette A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Gabriel P; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Feldman MJ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA., Park J; Departments of Medicine and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., de Rodas ML; Department of Pathology, Yale School of Medicine, New Haven, CT., Schalper KA; Department of Pathology, Yale School of Medicine, New Haven, CT., Goldfarb SB; Departments of Medicine and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical Center, New York, NY., Nayak A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA., Levine AJ; Institute for Advanced Study, Princeton, NJ., Greenbaum BD; Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Physiology, Biophysics & Systems Biology, Weill Cornell Medical Center, New York, NY., Maxwell KN; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 05. Date of Electronic Publication: 2024 Apr 05.

E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis.

Autor: Chang, Yu-Ping¹ (AUTHOR), Huang, Gong-Kai^2,3 (AUTHOR), Chen, Yung-Che^1,4 (AUTHOR), Huang, Kuo-Tung¹ (AUTHOR), Chen, Yu-Mu¹ (AUTHOR), Lin, Chiung-Yu¹ (AUTHOR), Huang, Chao-Cheng^2,5 (AUTHOR), Lin, Meng-Chih¹ (AUTHOR), Wang, Chin-Chou^1,4,6 (AUTHOR) ccwang5202@yahoo.com.tw

Publikováno v: BMC Cancer. 6/20/2023, Vol. 23 Issue 1, p1-11. 11p.